A research team at Tohoku University, in collaboration with Denka Company Limited and U-A Corporation, has developed a ...

EndoQuest Robotics has received FDA approval to proceed with the final enrollment phase of its pivotal Paradigm trial evaluating a robotic endoluminal system for gastrointestinal procedures. The ...

Endoscopic submucosal dissection to remove large colorectal lesions was performed safely and successfully in an outpatient setting, based on data from more than 600 patients. The widespread adoption ...

Prophylactic defect closure after endoscopic submucosal dissection (ESD) of the colon was associated with lower rates of delayed bleeding and post-procedure hospital admission, with the benefit more ...

Open-label phase 1/2 study evaluating the tolerability and antitumor activity of selinexor and pembrolizumab in colorectal cancer. A multicenter phase 2 trial of ramucirumab plus FOLFIRI as ...

ESD is performed with a thin, flexible endoscope inserted through the mouth or rectum. Using miniature tools, clinicians inject fluid to lift a precancerous or early cancer lesion from surrounding ...

Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...

A procedure pioneered overseas may now mean an easier recovery for some patients in the U.S. Almost half of all adults in the U.S. develop colon polyps during their lifetime, growths that are often ...

New data confirms younger and younger Americans are being diagnosed with colon cancer. The good news is new technology can remove early-stage cancers without surgery - but to catch it early, doctors ...

OAK BROOK, Ill. – January 27, 2009 – A prospective clinical trial from researchers in Japan shows magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer to be a ...